Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression

Martin Hasselblatt, Stefan Gesk, Florian Oyen, Sabrina Rossi, Elisabetta Viscardi, Felice Giangaspero, Caterina Giannini, Alexander R. Judkins, Michael C. Frühwald, Tobias Obser, Reinhard Schneppenheim, Reiner Siebert, Werner Paulus

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive brain tumors of early childhood poorly responding to therapy. The majority of cases show inactivation of SMARCB1 (INI1, hSNF5, BAF47), a core member of the adenosine triphosphate (ATP)-dependent SWI/SNF chromatin-remodeling complex. We here report the case of a supratentorial AT/RT in a 9-month-old boy, which showed retained SMARCB1 staining on immunohistochemistry and lacked genetic alterations of SMARCB1. Instead, the tumor showed loss of protein expression of another SWI/SNF chromatin-remodeling complex member, the ATPase subunit SMARCA4 (BRG1) due to a homozygous SMARCA4 mutation [c.2032C>T (p.Q678X)]. Our findings highlight the role of SMARCA4 in the pathogenesis of SMARCB1-positive AT/RT and the usefulness of antibodies directed against SMARCA4 in this diagnostic setting.

Original languageEnglish (US)
Pages (from-to)933-935
Number of pages3
JournalAmerican Journal of Surgical Pathology
Volume35
Issue number6
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Nonsense Codon
Chromatin Assembly and Disassembly
Neoplasm Antibodies
Brain Neoplasms
Adenosine Triphosphatases
Adenosine Triphosphate
Immunohistochemistry
Staining and Labeling
Mutation
Atypical Teratoid Tumor
Typical Teratoid Rhabdoid Tumor
Neoplasms
Proteins
Therapeutics

Keywords

  • atypical teratoid/rhabdoid tumor
  • BRG1
  • INI1
  • SMARCA4
  • SMARCB1

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. / Hasselblatt, Martin; Gesk, Stefan; Oyen, Florian; Rossi, Sabrina; Viscardi, Elisabetta; Giangaspero, Felice; Giannini, Caterina; Judkins, Alexander R.; Frühwald, Michael C.; Obser, Tobias; Schneppenheim, Reinhard; Siebert, Reiner; Paulus, Werner.

In: American Journal of Surgical Pathology, Vol. 35, No. 6, 06.2011, p. 933-935.

Research output: Contribution to journalArticle

Hasselblatt, M, Gesk, S, Oyen, F, Rossi, S, Viscardi, E, Giangaspero, F, Giannini, C, Judkins, AR, Frühwald, MC, Obser, T, Schneppenheim, R, Siebert, R & Paulus, W 2011, 'Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression', American Journal of Surgical Pathology, vol. 35, no. 6, pp. 933-935. https://doi.org/10.1097/PAS.0b013e3182196a39
Hasselblatt, Martin ; Gesk, Stefan ; Oyen, Florian ; Rossi, Sabrina ; Viscardi, Elisabetta ; Giangaspero, Felice ; Giannini, Caterina ; Judkins, Alexander R. ; Frühwald, Michael C. ; Obser, Tobias ; Schneppenheim, Reinhard ; Siebert, Reiner ; Paulus, Werner. / Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. In: American Journal of Surgical Pathology. 2011 ; Vol. 35, No. 6. pp. 933-935.
@article{e480defc5e9844558a9eab399b6dac73,
title = "Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression",
abstract = "Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive brain tumors of early childhood poorly responding to therapy. The majority of cases show inactivation of SMARCB1 (INI1, hSNF5, BAF47), a core member of the adenosine triphosphate (ATP)-dependent SWI/SNF chromatin-remodeling complex. We here report the case of a supratentorial AT/RT in a 9-month-old boy, which showed retained SMARCB1 staining on immunohistochemistry and lacked genetic alterations of SMARCB1. Instead, the tumor showed loss of protein expression of another SWI/SNF chromatin-remodeling complex member, the ATPase subunit SMARCA4 (BRG1) due to a homozygous SMARCA4 mutation [c.2032C>T (p.Q678X)]. Our findings highlight the role of SMARCA4 in the pathogenesis of SMARCB1-positive AT/RT and the usefulness of antibodies directed against SMARCA4 in this diagnostic setting.",
keywords = "atypical teratoid/rhabdoid tumor, BRG1, INI1, SMARCA4, SMARCB1",
author = "Martin Hasselblatt and Stefan Gesk and Florian Oyen and Sabrina Rossi and Elisabetta Viscardi and Felice Giangaspero and Caterina Giannini and Judkins, {Alexander R.} and Fr{\"u}hwald, {Michael C.} and Tobias Obser and Reinhard Schneppenheim and Reiner Siebert and Werner Paulus",
year = "2011",
month = "6",
doi = "10.1097/PAS.0b013e3182196a39",
language = "English (US)",
volume = "35",
pages = "933--935",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression

AU - Hasselblatt, Martin

AU - Gesk, Stefan

AU - Oyen, Florian

AU - Rossi, Sabrina

AU - Viscardi, Elisabetta

AU - Giangaspero, Felice

AU - Giannini, Caterina

AU - Judkins, Alexander R.

AU - Frühwald, Michael C.

AU - Obser, Tobias

AU - Schneppenheim, Reinhard

AU - Siebert, Reiner

AU - Paulus, Werner

PY - 2011/6

Y1 - 2011/6

N2 - Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive brain tumors of early childhood poorly responding to therapy. The majority of cases show inactivation of SMARCB1 (INI1, hSNF5, BAF47), a core member of the adenosine triphosphate (ATP)-dependent SWI/SNF chromatin-remodeling complex. We here report the case of a supratentorial AT/RT in a 9-month-old boy, which showed retained SMARCB1 staining on immunohistochemistry and lacked genetic alterations of SMARCB1. Instead, the tumor showed loss of protein expression of another SWI/SNF chromatin-remodeling complex member, the ATPase subunit SMARCA4 (BRG1) due to a homozygous SMARCA4 mutation [c.2032C>T (p.Q678X)]. Our findings highlight the role of SMARCA4 in the pathogenesis of SMARCB1-positive AT/RT and the usefulness of antibodies directed against SMARCA4 in this diagnostic setting.

AB - Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive brain tumors of early childhood poorly responding to therapy. The majority of cases show inactivation of SMARCB1 (INI1, hSNF5, BAF47), a core member of the adenosine triphosphate (ATP)-dependent SWI/SNF chromatin-remodeling complex. We here report the case of a supratentorial AT/RT in a 9-month-old boy, which showed retained SMARCB1 staining on immunohistochemistry and lacked genetic alterations of SMARCB1. Instead, the tumor showed loss of protein expression of another SWI/SNF chromatin-remodeling complex member, the ATPase subunit SMARCA4 (BRG1) due to a homozygous SMARCA4 mutation [c.2032C>T (p.Q678X)]. Our findings highlight the role of SMARCA4 in the pathogenesis of SMARCB1-positive AT/RT and the usefulness of antibodies directed against SMARCA4 in this diagnostic setting.

KW - atypical teratoid/rhabdoid tumor

KW - BRG1

KW - INI1

KW - SMARCA4

KW - SMARCB1

UR - http://www.scopus.com/inward/record.url?scp=79957975801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957975801&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e3182196a39

DO - 10.1097/PAS.0b013e3182196a39

M3 - Article

C2 - 21566516

AN - SCOPUS:79957975801

VL - 35

SP - 933

EP - 935

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 6

ER -